| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.28B | +9.1% | +11.1% |
| Cost of Revenue | $701.0M | +11.3% | +15.1% |
| R&D Expense | $92.0M | +4.5% | +13.6% |
| SG&A Expense | $159.0M | +3.2% | +1.9% |
| Interest Expense | $14.0M | — | — |
| Pre-tax Income | $272.0M | +6.7% | +8.8% |
| Income Tax | $49.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $128.0M | — | — |
| Accounts Receivable | $802.0M | — | — |
| Inventory | $647.0M | — | — |
| Current Assets | $1.62B | — | — |
| Total Assets | $12.51B | — | — |
| Current Liabilities | $910.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $782.0M | — | — |
| Investing Cash Flow | -$214.0M | — | — |
| Financing Cash Flow | -$616.0M | — | — |
| -14.0% |
| +14.0% |
| Net Income | $211.0M | +6.6% | +6.0% |
| EPS (Basic) | $1.01 | +12.2% | +6.3% |
| EPS (Diluted) | $1.01 | +12.2% | +6.3% |
| — |
| Long-term Debt | $1.72B | — | — |
| Total Liabilities | $3.13B | — | — |
| Stockholders' Equity | $9.12B | -18.5% | -17.7% |